Results 81 to 90 of about 577,044 (323)
Summary results of the Industry Conference on the Commercial Use of Space [PDF]
The future intentions of the Federal Republic of Germany in the area of the commercialization of space are presented. It is shown that significant advances in microgravity research, particulary in the areas of materials science, composite materials ...
REUSE, Thuerbach, R. P.
core +1 more source
Objective To evaluate the efficacy and safety of baricitinib in pediatric patients with active juvenile idiopathic arthritis–associated uveitis (JIA‐U) or chronic anterior antinuclear antibody–positive uveitis, who had an inadequate response to methotrexate (MTX) or biologic disease‐modifying antirheumatic drugs (bDMARDs).
Athimalaipet V. Ramanan +7 more
wiley +1 more source
Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in electronic health records. Methods We searched Medline, Embase, and Cochrane Central Register for Controlled Trials databases and included studies that validated case definitions against a ...
Constanza Saka‐Herrán +10 more
wiley +1 more source
Blindness to sponsor: Application to sports event posters [PDF]
Advertising posters in sports sponsorship are versatile marketing tools with significant media impact and high visibility. However, the academic literature on the impact of advertising posters in this field is scarce.
Manuel Alonso dos Santos +2 more
doaj
Congress Should Respond: A Payout for Some DAFs and New Rules for Noncash Contributions [PDF]
Donor advised funds attract a significant share of charitable giving and warrant Congress’s attention. The national sponsoring organization is distinct from other DAF sponsors.
Colinvaux, Roger
core
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
Background Identifying patients at increased risk of loss to follow-up (LTFU) is key to developing strategies to optimize the clinical management of tuberculosis (TB).
Moreno M. S. Rodrigues +11 more
doaj +1 more source
Donor-Advised Funds: An Overview Using IRS Data [PDF]
For nearly a decade, the Statistics of Income Division of the Internal Revenue Service (IRS) has been the primary source of data on donor advised funds (DAFs) sponsored by nonprofit charitable organizations tax-exempt under Section 501(c)(3) of the ...
Arnsberger, Paul
core
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner +14 more
wiley +1 more source
A two-period model of counterterrorism with terrorist sponsoring and the role of hatred
A two-period counterterrorism model is developed. One special case without terrorist sponsoring enables the government to degrade the terrorist’s resources substantially, especially with low unit counterterrorism cost or high asset valuations.
Kjell Hausken
doaj +1 more source

